Skip to content

ANSeR- The Algorithm for Neonatal Seizure Recognition Study

A Multicentre Clinical Evaluation of a Decision Support Algorithm for Neonatal Seizure Detection

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02160171
Acronym
ANSeR
Enrollment
240
Registered
2014-06-10
Start date
2013-04-30
Completion date
2015-06-30
Last updated
2015-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Seizures

Keywords

Decision Support Algorithm, Neonatal Seizures, EEG

Brief summary

A Multicentre Clinical Evaluation of a Decision Support Algorithm for Neonatal Seizure Detection: ANSeR

Detailed description

This is a multi-centre study. It will be based on routine clinical practice but will also allow for the off-line retrospective application of ANSeR to a well-defined clinical population in order to establish the potential diagnostic utility of the algorithm.

Interventions

DEVICEAlgorithm for Neonatal Seizure Recognition

Software system for neonatal seizure detection recognition

Sponsors

University College, London
CollaboratorOTHER
Wellcome Trust
CollaboratorOTHER
University College Cork
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
36 Weeks to No maximum
Healthy volunteers
No

Inclusion criteria

All term neonates at risk of seizures are eligible for the ANSeR study. Neonates ≥ 36 weeks gestation will be recruited if: They have a need for EEG monitoring.

Exclusion criteria

Consent of parents not obtained.

Design outcomes

Primary

MeasureTime frameDescription
To quantify the overall diagnostic accuracy of the Algorithm.up to 72 hoursTo measure diagnostic accuracy of ANSeR (Algorithm) and clinicians (in routine clinical practice or optimised clinical practice) during the initial up to but not limited to 72 hour period of post-natal EEG monitoring, using an expert panel as the reference standard.

Secondary

MeasureTime frameDescription
Inappropriate use/non-use of Anti Epileptic Drugs (AEDs)up to 72 hoursTo quantify the degree and duration of inappropriate use/non-use of AEDs with 1. the off-line application of the ANSeR algorithm and 2. routine clinical practice. To compare (a) and (b).
To examine factors that influence diagnostic accuracy in clinical practice.up to 72 hoursTo examine factors that influence diagnostic accuracy in clinical practice.

Countries

Ireland, Netherlands, Sweden, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026